Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.68% is 50% above its 5-year average of 2.45%, around the middle of its 5-year range (0.26%–7.51%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.68% below its 12-month average of 3.98%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.68%.
DEBT TO ASSETS RATIO
3.68%
DEBT TO ASSETS RATIO AVG TTM
3.98%
DEBT TO ASSETS RATIO AVG 3Y
2.03%
DEBT TO ASSETS RATIO AVG 5Y
2.45%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.68%
CURRENT VS 3Y AVG
+81.28%
CURRENT VS 5Y AVG
+49.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 847 covered companies
CURRENT VS SECTOR MEDIAN
+3987.51%
vs the sector median at left
Market Cap
$9.56B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.99B
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.99B
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.01B
Debt to Assets Ratio
0.23%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.41B | 3.68% | 3.98% | 2.03% | 2.45% |
| Insulet Corp. (PODD)vs › | $9.37B | 0.30% | N/A | N/A | N/A |
| Krystal Biotech, Inc. (KRYS)vs › | $9.56B | 0.01% | N/A | N/A | N/A |
| Bruker Corporation (BRKR)vs › | $9.25B | 0.32% | N/A | N/A | N/A |
| Henry Schein, Inc. (HSIC)vs › | $9.64B | 0.34% | N/A | N/A | N/A |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.99B | 0.29% | N/A | N/A | N/A |
| Bruker Corporation (BRKRP)vs › | $8.98B | 0.32% | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.99B | 0.12% | N/A | N/A | N/A |
| Repligen Corporation (RGEN)vs › | $10.01B | 0.23% | N/A | N/A | N/A |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.80B | 0.01% | N/A | N/A | N/A |
Debt/Assets
3.7%
Debt/Equity
0.04
Current Ratio
5.72
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.68% |
| 2026-03-31 | 3.47% |
| 2025-12-31 | 7.51% |
| 2025-09-30 | 2.66% |
| 2025-06-30 | 2.60% |
| 2025-03-31 | 2.58% |
| 2024-12-31 | 2.03% |
| 2024-09-30 | 0.79% |
| 2024-06-30 | 1.23% |
| 2024-03-31 | 1.31% |
| 2023-12-31 | 2.08% |
| 2023-09-30 | 0.92% |
| 2023-06-30 | 1.01% |
| 2023-03-31 | 1.65% |
| 2022-12-31 | 1.78% |
| 2022-09-30 | 4.80% |
| 2022-06-30 | 5.15% |
| 2022-03-31 | 5.56% |
| 2021-12-31 | 5.17% |
| 2021-09-30 | 0.33% |
| 2021-06-30 | 0.26% |
| 2021-03-31 | 0.30% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.25% |
